News for BIOGEN INC (BIIBCL.SN)

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a leading cause of ki

Biogen Inc. (NASDAQ:BIIB) Leerink Global Healthcare Conference 2025 March 10, 2025 11:20 AM ETCompany ParticipantsAlisha Alaimo - President of North...

Shares of Biogen Inc (BIIB) surged 3.42% in mid-day trading on Mar 10. The stock reached an intraday high of $157.09, before settling at $155.53, up from it

Shares of Biogen Inc (BIIB) surged 3.32% in mid-day trading on Mar 7. The stock reached an intraday high of $154.24, before settling at $152.27, up from its

Biogen Inc. (NASDAQ:BIIB) TD Cowen 45th Annual Health Care Conference March 3, 2025 9:10 AM ETCompany ParticipantsChris Viehbacher - CEOConference Call...

Biogen Inc (BIIB) and Eisai Co., Ltd. announced on February 28, 2025, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines A

PR NewswireTOKYO and CAMBRIDGE, Mass., Feb. 28, 2025 TOKYO and CAMBRIDGE, Mass., Feb. 28, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: H

While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Biogen Inc.

Stoke retains exclusive rights for zorevunersen in the United States, Canada, and Mexico; Biogen receives exclusive rest of world commercialization rights

Biogen Inc BIIB reported better-than-expected earnings for its fourth quarter on Wednesday. The company posted fourth-quarter adjusted EPS of $3.44, up 17%, be...

Total Revenue (Q4 2024): $2.5 billion, 3% growth from Q4 2023.Total Revenue (Full Year 2024): $9.7 billion, 2% decline from 2023.Non-GAAP Diluted EPS (Q4 2024)

Biogen Inc's robust product portfolio and strategic collaborations position it as a leader in neurology and rare diseases.Despite strong market presence, paten

Feb 12, 2025 / 01:30PM GMTOperator Good morning. My name is Jennifer, and I will be your conference operator today. At this time, I'd like to welcome everyone t

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New York.

Stock Market Today saw a sharp decline as the Dow Jones plummeted 400 points following a rise in US Inflation to 3% YoY. The latest CPI data released by the US Bureau of Labor Statistics dampened investor hopes for Federal Reserve rate cuts. The S&P 500 and Nasdaq Composite also opened lower, reflecting market uncertainty. Key stocks like Microsoft, Amazon, and Nike took a hit, while Apple and JPMorgan managed gains. With inflation higher than expected, the Feds stance on interest rates remains firm, adding to market volatility. Investors are closely watching for future economic cues.

Biogen Inc. (NASDAQ:BIIB) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher -...

Shares of Biogen Inc (BIIB) fell 4.37% in mid-day trading on Feb 12. The stock reached an intraday low of $128.51, before recovering slightly to $133.30, do

The following slide deck was published by Biogen Inc.